Sartorius AG (SRT4)
Market Open
11 Aug, 06:01
XMUN 
€
38. 20
+0.6
+1.5957%
€
6.71B Market Cap
- P/E Ratio
0.63% Div Yield
0 Volume
- Eps
€ 37.6
Previous Close Want to track SRT4 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SRT4 trading today higher at €38.2, an increase of 1.5957% from yesterday's close, completing a monthly increase of 3.2432% or €1.2. Over the past 12 months, SRT4 stock gained 3.2432%.
SRT4 is not paying dividends to its shareholders.
The last earnings report, released on Apr 14, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
SRT4 Chart
People also search for
Sartorius AG (SRT4) FAQ
What is the stock price today?
The current price is €38.20.
On which exchange is it traded?
Sartorius AG is listed on XMUN.
What is its stock symbol?
The ticker symbol is SRT4.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.63%.
What is its market cap?
As of today, the market cap is 6.71B.
Has Sartorius AG ever had a stock split?
No, there has never been a stock split.
Sartorius AG Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Dr. Michael Grosse CEO | XMUN Exchange | US80385Q1094 ISIN |
| DE Country | 13,299 Employees | 30 Mar 2026 Last Dividend | - Last Split | - IPO Date |
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Contact Information
Address: Otto-Brenner-Strasse 20, Göttingen, Germany, 37079
Phone: 49 551 308 0
Website: https://www.sartorius.com
